TrialTrials2013

Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial.

Matthew P Leighton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.